IGM Biosciences, Inc. (IGMS)
NASDAQ: IGMS · IEX Real-Time Price · USD
10.74
+0.03 (0.28%)
At close: Jul 19, 2024, 4:00 PM
10.41
-0.33 (-3.07%)
Pre-market: Jul 22, 2024, 5:11 AM EDT
IGM Biosciences Market Cap
IGM Biosciences has a market cap or net worth of $633.91 million as of July 22, 2024. Its market cap has increased by 58.64% in one year.
Market Cap
633.91M
Enterprise Value
380.75M
1-Year Change
58.64%
Ranking
Category
Stock Price
$10.74
Market Cap Chart
Since September 18, 2019, IGM Biosciences's market cap has decreased from $702.10M to $633.91M, a decrease of -9.71%. That is a compound annual growth rate of -2.09%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 19, 2024 | 633.90M | 30.62% |
| Dec 29, 2023 | 485.30M | -33.38% |
| Dec 30, 2022 | 728.50M | -23.48% |
| Dec 31, 2021 | 952.10M | -64.87% |
| Dec 31, 2020 | 2.71B | 132.63% |
| Dec 31, 2019 | 1.17B | 65.96% |
View and export this data all the way back to 2019.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Exscientia | 649.15M |
| Acelyrin | 644.67M |
| Arcturus Therapeutics Holdings | 640.71M |
| Phathom Pharmaceuticals | 640.67M |
| Prime Medicine | 636.76M |
| Pediatrix Medical Group | 632.79M |
| PetIQ | 630.85M |
| Entrada Therapeutics | 630.40M |